This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
The historical rank and industry rank for Ramsay Generale dente's Median PS Value or its related term are showing as below:
XPAR:GDS's Price-to-Median-PS-Value is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 0.7 * Ranked among companies with meaningful Price-to-Median-PS-Value only.
Ramsay Generale dente (XPAR:GDS) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Ramsay Generale dente's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
11.40
/
0.00
=
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ramsay Generale dente Median PS Value Related Terms
Ramsay Generale dente Median PS Value Historical Data
* Premium members only.
The historical data trend for Ramsay Generale dente's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XPAR:GDS vs HCA, THC, DVA: Median PS Value Comparison
For the Medical Care Facilities subindustry, Ramsay Generale dente's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ramsay Generale dente Price-to-Median-PS-Value vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Ramsay Generale dente's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Ramsay Generale dente's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 0.
Ramsay Generale dente's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €24.195.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ramsay Generale dente (XPAR:GDS) has a Median PS Value of €0.00 as of Jun. 30, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Ramsay Generale dente and its competitors. According to the industry distribution chart, Ramsay Generale dente ranks #999999 out of 262 companies in the Healthcare Providers & Services industry.
Is Ramsay Generale dente's Median PS Value too high?
Ramsay Generale dente's current Median PS Value is €0.00. Based on the distribution chart, Ramsay Generale dente ranks #999999 out of 262 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Ramsay Generale dente has a GF Score™ of 69/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Ramsay Generale dente's Median PS Value compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Ramsay Generale dente ranks #999999 out of 262 companies for Median PS Value. This places Ramsay Generale dente in the lower half of its industry. The industry median Median PS Value is 0.70. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Healthcare Providers & Services company?
The median Median PS Value among Healthcare Providers & Services companies is 0.70, based on 262 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Ramsay Generale dente and its competitors. For the Healthcare Providers & Services industry, the median Median PS Value is 0.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ramsay Generale dente's current Median PS Value is €0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ramsay Generale dente stock overvalued right now?
Based on GuruFocus' analysis, Ramsay Generale dente (XPAR:GDS) is currently considered Possible Value Trap. The stock's GF Value™ is €21.72, compared to a current price of €11.40 — trading 47.5% below its estimated fair value. The current Median PS Value is €0.00. Ramsay Generale dente's overall GF Score™ is 69/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Ramsay Generale dente (XPAR:GDS), the current Median PS Value is €0.00 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ramsay Generale dente (XPAR:GDS) Overvalued in 2026?
Based on GuruFocus' analysis, Ramsay Generale dente stock appears to be undervalued.
The current stock price of €11.40 is trading 47.5% below its estimated GF Value™ of €21.72.
GuruFocus considers Ramsay Generale dente to be Possible Value Trap.
Key valuation signals for XPAR:GDS:
Median PS Value: €0.00
GF Value™: €21.72 vs. price of €11.40 (47.5% below fair value)
No single metric tells the full story. See the XPAR:GDS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ramsay Generale de Sante SA operates in the private healthcare sector in France. The company provides a comprehensive range of patient care services in thirteen business segments: Nouvelle Aquitaine, Bourgogne-Franche Comte, Brittany, Centre-Val de Loire, Hauts de France, Normandy, Provence Alpes Cote d'Azur, Ile de France, Auvergne-Rhone Alpes, Occitanie, Italy, Nordics, and Head Office. It generates maximum revenue from the Ile de France segment. The company also specializes in cardiology, heart surgery, digestive surgery, dermatology, urology, ophthalmology, vascular and endovascular surgery.
69GF Score
Get the complete analysis for XPAR:GDS
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XPAR:GDS has been successfully added to your 
